المؤلفون: A. A. Studenikina, E. S. Mikhaylova, S. A. Arkhipov, N. A. Varaksin, A. V. Proskura, A. I. Autenshlyus, А. А. Студеникина, Е. С. Михайлова, С. А. Архипов, Н. А. Вараксин, А. В. Проскура, А. И. Аутеншлюс

المساهمون: Финансирование исследования осуществлялось за счет государственного задания Министерства здравоохранения Российской Федерации (№ АААА-А18-118030790008-7).

المصدر: Medical Immunology (Russia); Том 25, № 2 (2023); 357-366 ; Медицинская иммунология; Том 25, № 2 (2023); 357-366 ; 2313-741X ; 1563-0625

مصطلحات موضوعية: рак молочной железы, proteins, Ki-67, proliferation, metastasis, breast cancer, протеины, пролиферация, метастазирование

وصف الملف: application/pdf

Relation: https://www.mimmun.ru/mimmun/article/view/2570/1652; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9914; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9918; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9919; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9921; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9923; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9924; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9925; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9926; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9927; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9928; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9929; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9947; https://www.mimmun.ru/mimmun/article/downloadSuppFile/2570/9948; Аутеншлюс А.И., Бернадо А.В., Давлетова К.И., Архипов С.А., Жураковский И.П., Михайлова Е.С., Проскура А.В., Богачук А.П., Липкин В.М., Ляхович В.В. Белковые и иммуногистохимические маркеры заболеваний молочной железы // Биомедицинская химия, 2020. Т. 66, № 2. С. 163-173.; Давлетова К.И., Михайлова Е.С., Вараксин Н.А., Жураковский И.П., Проскура А.В., Сидоров С.В., Аутеншлюс А.И. Продукция цитокинов иммунокомпетентными клетками крови у больных инвазивной карциномой молочной железы неспецифического типа в различных возрастных группах при лимфогенном метастазировании // Медицинская иммунология, 2019. Т. 21, № 6. С. 1115-1126. doi:10.15789/1563-0625-2019-6-1115-1126.; Arafah M.A., Ouban A., Ameer O.Z., Quek K.J. KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance. Breast Cancer (Auckl.), 2021, Vol. 30, no. 15, 11782234211016977. doi:10.1177/11782234211016977.; Asaoka M., Patnaik S.K., Zhang F., Ishikawa T., Takabe K. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response. Breast Сancer Res. Treat., 2020, Vol. 181, no. 2, pp. 309-322.; Baram T., Rubinstein-Achiasaf L., Ben-Yaakov H., Ben-Baruch A. Inflammation-driven breast tumor cell plasticity: Stemness/EMT, therapy resistance and dormancy. Front. Oncol., 2021, Vol. 10, 614468. doi:10.3389/ fonc.2020.614468.; Ben-Baruch A. Tumor necrosis factor α: Taking a personalized road in cancer therapy. Front. Immunol., 2022, Vol. 13, 903679. doi:10.3389/fimmu.2022.903679.; Humphries B.A., Buschhaus J.M., Chen Y.C., Haley H.R., Qyli T., Chiang B., Shen N., Rajendran S., Cutter A., Cheng Y.-H., Chen Y.-T., Cong J., Spinosa P.C., Yoon E,. Luker K.E., Luker G.D. Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer. Mol. Cancer Res., 2019, Vol. 17, no. 5, pp. 1142-1154.; Lampelj M., Arko D., Cas-Sikosek N., Kavalar R., Ravnik M., Jezersek-Novakovic B., Dobnik S., Dovnik N.F., Takac I. Urokinase plasminogen activator (uPA) and plasminogen ac-tivator inhibitor type-1 (PAI-1) in breast cancer – correlation with traditional prognostic factors. Radiol. Oncol., 2015, Vol. 49, no. 4, pp. 357-364.; Liang Q., Ma D., Gao R.F., Yu K.D. Effect of Ki-67 Expression levels and histological grade on breast cancer early relapse in patients with different immunohistochemical-based subtypes. Sci. Rep., 2020, Vol. 10, no. 1, 7648. doi:10.1038/s41598-020-64523-1.; Łukaszewicz-Zając M., Pączek S., Mroczko B. The significance of chemokine CXCL-8 in esophageal carcinoma. Arch. Med. Sci., 2020, Vol. 16, no. 2, pp. 475-480.; Maranta A.F., Broder S., Fritzsche C., Knauer M., Thürlimann B., Jochum W., Ruhstaller T. Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer. Breast, 2020, Vol. 51, pp. 120-126.; Mariotto A.B., Etzioni R., Hurlbert M., Penberthy L., Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol. Biomark. Prev., 2017, Vol. 26, pp. 809-815.; Matutino A., Joy A.A., Brezden-Masley C., Chia S., Verma S. Hormone receptor-positive, HER2-negative metastatic breast cancer: redrawing the lines. Curr. Oncol., 2018, Vol. 25, pp. 131-141.; Mercogliano M.F., Bruni S., Elizalde P.V., Schillaci R. Tumor necrosis factor α blockade: an opportunity to tackle breast cancer. Front. Oncol., 2020, Vol. 10, 584. doi:10.3389/fonc.2020.00584.; Narita D., Seclaman E., Anghel A., Ilina R., Cireap N., Negru S., Sirbu I.O., Ursoniu S., Marian C. Altered levels of plasma chemokines in breast cancer and their association with clinical and pathological characteristics. Neoplasma, 2016, Vol. 63, no. 1, pp. 141-149.; Petrelli F., Viale G., Cabiddu M., Barni S. Prognostic value of different cut-off levels of KI 67 in breast cancer: a systematic review and meta-analysis of 64,196 patients. Breast Cancer Res. Treat., 2015, Vol. 153, pp. 477-491.; Posso M., Corominas J.M., Serrano L., Román M., Torá-Rocamora I., Domingo L., Romero A.,Quintana M.J., Vernet-Tomas M., Baré M., Vidal C., Sánchez M., Saladié F., Natal C., Ferrer J., Servitja S., Sala M., Castells X.; BELE Study Group. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study. Cancer Med., 2017, Vol. 6, no. 6, pp. 1482-1489.; Sarode P., Schaefer M.B., Grimminger F., Seeger W., Savai R. Macrophage and tumor cell cross-talk is fundamental for lung tumor progression: we need to talk. Front. Oncol., 2020, Vol. 10, 324. doi:10.3389/ fonc.2020.00324.; Savci-Heijink C.D., Halfwerk H., Hooijer G.K.J., Koster J., Horlings H.M., Meijer S.L., van de Vijver M.J. Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior. Breast Cancer Res. Treat., 2019, Vol. 174, pp. 649-659.; Siersbæk R., Scabia V., Nagarajan S., Chernukhin I., Papachristou E.K., Broome R., Johnston S.J., Joosten S.E.P., Green A.R., Kumar S., Jones J., Omarjee S., Alvarez-Fernandez R., Glont S., Aitken S.J., Kishore K., Cheeseman D., Rakha E.A., D'Santos C., Zwart W., Russell A., Brisken C., Carroll J.S. IL6/STAT3 signaling hijacks estrogen receptor α enhancers to drive breast cancer metastasis. Cancer Сell., 2020, Vol. 38, no. 3, pp. 412-423.; Sommariva M., Gagliano N. E-Cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT. Cells, 2020, Vol. 9, no. 4, 1040. doi:10.3390/cells9041040.; Völker H.U., Weigel M., Strehl A., Frey L. Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array. Diagn. Pathol., 2018, Vol. 13, no. 1, 67. doi:10.1186/s13000-018- 0737-5.; Yu P.F., Huang Y., Han Y.Y., Lin L.Y., Sun W.H., Rabson A.B., Wang Y., Shi Y.F. TNF alpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2 (+) neutrophils. Oncogene, 2017, Vol. 36, pp. 482-490.; Zhang S., Zhang D., Yi S., Gong M., Lu C., Cai Y., Tang X., Zou L. The relationship of lymphatic vessel density, lymphovascular invasion, and lymph node metastasis in breast cancer: a systematic review and metaanalysis. Oncotarget, 2017, Vol. 8, no. 2, pp. 2863-2873.; https://www.mimmun.ru/mimmun/article/view/2570

الاتاحة: https://www.mimmun.ru/mimmun/article/view/2570
https://doi.org/10.15789/10.15789/1563-0625-BBA-2570

المؤلفون: A. V. Proskura, Yu. G. Alyaev, V. V. Borisov, D. V. Butnaru, L. M. Rapoport, E. S. Sirota, A. Yu. Suvorov, D. N. Fiev, E. V. Shpot, E. A. Bezrukov, M. E. Enikeev, G. N. Akopyan, D. O. Korolev, A. A. Vorobiev, M. M. Chernenkiy, I. M. Chernenkiy, Kh. M. Ismailov, Z. S. Shomukimova, А. В. Проскура, Ю. Г. Аляев, В. В. Борисов, Д. В. Бутнару, Л. М. Рапопорт, Е. С. Сирота, А. Ю. Суворов, Д. Н. Фиев, Е. В. Шпоть, Е. А. Безруков, М. Э. Еникеев, Г. Н. Акопян, Д. О. Королев, A. А. Воробьев, М. М. Черненький, И. М. Черненький, Х. М. Исмаилов, З. С. Шомукимова

المصدر: Andrology and Genital Surgery; Том 24, № 3 (2023); 66-74 ; Андрология и генитальная хирургия; Том 24, № 3 (2023); 66-74 ; 2412-8902 ; 2070-9781

مصطلحات موضوعية: клубочковая фильтрация, renal function, computed tomography, glomerular filtration, функция, компьютерная томография

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/684/534; Campbell S.C., Novick A.C., Belldegrun A. et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9. DOI:10.1016/j.juro.2009.07.004; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; MacLennan S., Imamura M., Lapitan M.C. et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 2012;62(6):1097–117. DOI:10.1016/j.eururo.2012.07.028; Liss M.A., Wang S., Palazzi K. et al. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 2014;14:101. DOI:10.1186/1471-2490-14-101; Fergany A.F., Hafez K.S., Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163(2):442–5. PMID: 10647650.; Capitanio U., Terrone C., Antonelli A. et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a–T1b renal mass and normal preoperative renal function. Eur Urol 2015;67(4):683–9. DOI:10.1016/j.eururo.2014.09.027; MacLennan S., Imamura M., Lapitan M.C. et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012;61(5):972–93. DOI:10.1016/j.eururo.2012.02.039; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51–7. DOI:10.1016/j.juro.2012.03.006; Scosyrev E., Messing E.M., Sylvester R. et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372–7. DOI:10.1016/j.eururo.2013.06.044; Kim C.S., Bae E.H., Ma S.K. et al. Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma. BMC Nephrol 2014;15:181. DOI:10.1186/1471-2369-15-181; McCallum W., Testani J.M. Updates in cardiorenal syndrome. Med Clin North Am 2023;107(4):763–80. DOI:10.1016/j.mcna.2023.03.011; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51(6):1606–15. DOI:10.1016/j.eururo.2006.11.013; Antonelli A., Ficarra V., Bertini R. et al. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study. BJU Int 2012;109(7):1013–8. DOI:10.1111/j.1464-410X.2011.10431.x; Gong I.H., Hwang J., Choi D.K. et al. Relationship among total kidney volume, renal function and age. J Urol 2012;187(1):344–9. DOI:10.1016/j.juro.2011.09.005; Jeon H.G., Gong I.H., Hwang J.H. et al. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy. BJU Int 2012;109(10):1468–73. DOI:10.1111/j.1464-410X.2011.10531.x; Tobert C.M., Boelkins B., Culver S. et al. Surgeon assessment of renal preservation with partial nephrectomy provides information comparable to measurement of volume preservation with 3D image analysis. J Urol 2014;191(5):1218–24. DOI:10.1016/j.juro.2013.11.003; Eum S.H., Lee H., Ko E.J. et al. Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors. Sci Rep 2022;12(1):5144. DOI:10.1038/s41598-022-09187-9; Hori Y., Obinata D., Funakoshi D. et al. Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinoma. Clin Exp Nephrol 2021;25(3):315–21. DOI:10.1007/s10157-020-01984-8; Yanishi M., Kinoshita H., Yoshida T. et al. Comparison of renal scintigraphy and computed tomographic renal volumetry for determining split renal function and estimating post-transplant renal function. Transplant Proc 2015;47(9):2700–2. DOI:10.1016/j.transproceed.2015.07.037; Almeida M., Pereira P.R., Ramos M. et al. CT volumetry performs better than nuclear renography in predicting estimated renal function one year after living donation. Int Urol Nephrol 2023;55(3):553–62. DOI:10.1007/s11255-022-03441-9; You S., Ma X., Zhang C. et al. Determination of single-kidney glomerular filtration rate (GFR) with CT urography versus renal dynamic imaging Gates method. Eur Radiol 2018;28(3):1077–84. DOI:10.1007/s00330-017-5061-z; Diez A., Powelson J., Sundaram C.P. et al. Correlation between CT-based measured renal volumes and nuclear-renography-based split renal function in living kidney donors. Clinical diagnostic utility and practice patterns. Clin Transplant 2014;28(6):675–82. DOI:10.1111/ctr.12365; Nilsson H., Wadström J., Andersson L.G. et al. Measuring split renal function in renal donors: can computed tomography replace renography? Acta Radiol 2004;45(4):474–80. DOI:10.1080/02841850410005282; Tsushima Y., Blomley M.J., Okabe K. et al. Determination of glomerular filtration rate per unit renal volume using computerized tomography: correlation with conventional measures of total and divided renal function. J Urol 2001;165(2):382–5. DOI:10.1097/00005392-200102000-00007; Hackstein N., Buch T., Rau W.S. et al. Split renal function measured by triphasic helical CT. Eur J Radiol 2007;61(2):303–9. DOI:10.1016/j.ejrad.2006.09.001; Helck A., Schonermarck U., Habicht A. et al. Determination of split renal function using dynamic CT-angiography: preliminary results. PloS One 2014;9(3):e91774. DOI:10.1371/journal.pone.0091774; Summerlin A.L., Lockhart M.E., Strang A.M. et al. Determination of split renal function by 3D reconstruction of CT angiograms: a comparison with gamma camera renography. AJR Am J Roentgenol 2008;191(5):1552–8. DOI:10.2214/AJR.07.4023; Hua L., Sebben R., Olakkengil S. et al. Correlation between computed tomography volumetry and nuclear medicine split renal function in live kidney donation: a single-centre experience. ANZ J Surg 2020;90(7–8):1347–51. DOI:10.1111/ans.16087; Shi W., Liang X., Wu N. et al. Assessment of split renal function using a combination of contrast-enhanced CT and serum creatinine values for glomerular filtration rate estimation. AJR Am J Roentgenol 2020;215(1):142–7. DOI:10.2214/AJR.19.22125; Lal H., Yadav P., Kaul A. et al. Role of computed tomography in estimation of residual renal function at one year after donor nephrectomy: comparison with nuclear scintigraphy. Saudi J Kidney Dis Transpl 2021;32(4):993–8. DOI:10.4103/1319-2442.338312; Patankar K., Low R.S., Blakeway D., Ferrari P. Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation. Acta Radiol 2014;55(6):753–60. DOI:10.1177/0284185113504195; Barbas A.S., Li Y., Zair M. et al. CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. Clin Transplant 2016;30(9):1028–35. DOI:10.1111/ctr.12784; Mitsui Y., Sadahira T., Araki M. et al. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol 2018;22(2):453–58. DOI:10.1007/s10157-017-1454-1; Houbois C., Haneder S., Merkt M. et al. Can computed tomography volumetry of the renal cortex replace MAG3-scintigraphy in all patients for determining split renal function? Eur J Radiol 2018;103:105–11. DOI:10.1016/j.ejrad.2018.04.016; Fiev D., Proskura A., Khokhlachev S. et al. A prospective study of novel mathematical analysis of the contrast-enhanced computed tomography vs renal scintigraphy in renal function evaluation. Eur J Radiol 2020;130:109169. DOI:10.1016/j.ejrad.2020.109169; Фиев Д.Н. Виртуальное моделирование для выбора метода лечения и планирования операций при хирургических заболеваниях почек. Дис. д-ра мед. наук. М., 2015.; Сирота Е.С. Компьютер-ассистированные операции при заболеваниях почки. Дис. . д-ра мед. наук. М., 2018.; Проскура А.В. Оценка функции почки с помощью трехмерной виртуальной обработки данных МСКТ с контрастированием. Дис. . канд. мед. наук. М., 2020.; Попов С.В., Гусейнов Р.Г., Борисенков М.Б. и др. Сравнительная оценка выживаемости пациентов с раком почки после эндовидеохирургической радикальной нефрэктомии и резекции почки. Онкоурология 2013;9(2):21–5. DOI:10.17650/1726-9776-2013-9-2-21-25; Ракул С.А., Поздняков К.В., Елоев Р.А. Отдаленные онкологические результаты хирургического лечения локализованных опухолей почек. Онкоурология 2021;17(4):27–37. DOI:10.17650/1726-9776-2021-17-4-27-37; Котов С.В., Неменов А.А., Юсуфов А.Г. и др. Сравнение периоперационных и ранних функциональных результатов лапароскопической резекции почки с опухолью при стадии cT1aN0M0 и cT1b–T2aN0M0. Онкоурология 2021;17(4):38–46. DOI:10.17650/1726-9776-2021-17-4-38-46; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;10(3):22–30. DOI:10.17650/1726-9776-2014-10-3-22-30; Larcher A., Wallis C.J.D., Pavan N. et al. Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database. Cent European J Urol 2020;73(3):273–9. DOI:10.5173/ceju.2020.0179; Porpiglia F., Fiori C., Bertolo R. et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol 2012;62(1):130–5. DOI:10.1016/j.eururo.2012.02.001; Pansadoro A., Cochetti G., D’amico F. et al. Retroperitoneal laparoscopic renal tumour enucleation with local hypotension on demand. World J Urol 2015;33(3):427–32. DOI:10.1007/s00345-014-1325-2; Rod X., Peyronnet B., Seisen T. et al. Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int 2016;118(5):692–705. DOI:10.1111/bju.13580; Jiang Y.L., Peng C.X., Wang H.Z., Qian LJ. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis. BMC Urol 2019;19(1):48. DOI:10.1186/s12894-019-0480-6; https://agx.abvpress.ru/jour/article/view/684

الاتاحة: https://agx.abvpress.ru/jour/article/view/684
https://doi.org/10.17650/2070-9781-2023-24-3-66-74

المؤلفون: D. V. Chinenov, E. V. Shpot, H. M. Ismailov, A. V. Proskura, Ya. N. Chernov, L. M. Rapoport, D. O. Korolev, A. N. Gerasimov, Д. В. Чиненов, Е. В. Шпоть, Х. М. Исмаилов, А. В. Проскура, Я. Н. Чернов, Л. М. Рапопорт, Д. О. Королев, А. Н. Герасимов

المصدر: Andrology and Genital Surgery; Том 24, № 1 (2023); 100-114 ; Андрология и генитальная хирургия; Том 24, № 1 (2023); 100-114 ; 2412-8902 ; 2070-9781

مصطلحات موضوعية: эректильная дисфункция, urethral stricture, erectile dysfunction, стриктура уретры

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/641/508; Santucci R.A., Joyce G.F., Wise M. Male urethral stricture disease. J Urol 2007;177(5):1667–74. DOI:10.1016/j.juro.2007.01.041; Palminteri E., Berdondini E., Verze P. et al. Contemporary urethral stricture characteristics in the developed world. Urology 2013;81(1):191–6. DOI:10.1016/j.urology.2012.08.062; 3Lumen N., Hoebeke P., Willemsen P. et al. Etiology of urethral stricture disease in the 21st century. J Urol 2009;182(3):983–7. DOI:10.1016/j.juro.2009.05.023; Hampson L.A., Mcaninch J.W., Breyer B.N. Male urethral strictures and their management. Nat Rev Urol 2014;11(1):43–50. DOI:10.1038/nrurol.2013.275; Palminteri E., Berdondini E., De Nunzio C. et al. The impact of ventral oral graft bulbar urethroplasty on sexual life. Urology 2013;81(4):891–8.; Sangkum P., Levy J., Yafi F.A., Hellstrom W.J.G. Erectile dysfunction in urethral stricture and pelvic fracture urethral injury patients: diagnosis, treatment, and outcomes. Andrology 2015;3(3):443–9. DOI:10.1111/andr.12015; Chapple C., Andrich D., Atala A. et al. SIU/ICUD consultation on urethral strictures: the management of anterior urethral stricture disease using substitution urethroplasty. Urology 2014;83(3 Suppl): S31–47. DOI:10.1016/j.urology.2013.09.012; Mundy A.R., Andrich D.E. Urethral strictures. BJU Int 2011;107(1):6–26. DOI:10.1111/j.1464-410X.2010.09800.x; Erickson B.A., Wysock J.S., McVary K.T. et al. Erectile function, sexual drive, and ejaculatory function after reconstructive surgery for anterior urethral stricture disease. BJU Int 2007;99(3):607–11. DOI:10.1111/j.1464-410X.2006.06669.x; Moher D., Shamseer L., Clarke M. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4(1):1. DOI:10.1186/2046-4053-4-1; Mazzone A., Anderson R., Voelzke B.B. et al. Sexual function following pelvic fracture urethral injury and posterior urethroplasty. Transl Androl Urol 2021;10(5):2043–50. DOI:10.21037/tau-20-1287; Enganti B., Reddy M.S., Chiruvella M. et al. Double-face augmentation urethroplasty for bulbar urethral strictures: analysis of short-term outcomes. Turk J Urol 2020;46(5):383–7. DOI:10.5152/tud.2020.20106; D’hulst P., Floyd M.S. Jr., Castiglione F. et al. Excision and primary anastomosis for bulbar urethral strictures improves functional outcomes and quality of life: a prospective analysis from a single centre. Biomed Res Int 2019;2019:7826085. DOI:10.1155/2019/7826085; Angulo J.C., Dorado J.F., Policastro C.G. et al. Multi-institutional study of dorsal onlay urethroplasty of the membranous urethra after endoscopic prostate procedures: operative results, continence, erectile function and patient reported outcomes. J Clin Med 2021;10(17):3969. DOI:10.3390/jcm10173969; Bertrand L.A., Voelzke B.B., Elliott S.P. et al. Measuring and predicting patient dissatisfaction after anterior urethroplasty using patient reported outcomes measures. J Urol 2016;196(2):453–61. DOI:10.1016/j.juro.2016.01.117; Omar R.G., Khalil M.M., Alezaby H. et al. Evaluation of erectile function after anastomotic vs substitutional urethroplasty for bulbar urethral stricture. Arab J Urol 2020;18(4):226–32. DOI:10.1080/2090598X.2020.1805965; Singh U.P., Maheshwari R., Kumar V. et al. Impact on sexual function after reconstructive surgery for anterior urethral stricture disease. Indian J Urol 2010;26(2):188–92. DOI:10.4103/0970-1591.65384; Tyagi S., Parmar K., Sharma A. et al. Dorsolateral inner preputial graft urethroplasty for anterior urethral strictures: long-term outcomes from a single tertiary care centre. World J Urol 2021;39(9):3549–54. DOI:10.1007/s00345-021-03613-9; Sachin D., Chikka Moga Siddaiah M., Vilvapathy Senguttuvan K. et al. Incidence of de novo erectile dysfunction after urethroplasty: a prospective observational study. World J Mens Health 2017;35(2):94–9. DOI:10.5534/wjmh.2017.35.2.94; Kałużny A., Krukowski J., Matuszewski M. Erectile dysfunction after urethroplasty. Cent European J Urol 2019;72(4):402–7. DOI:10.5173/ceju.2019.1737; Soave A., Kluth L., Dahlem R. et al. Outcome of buccal mucosa graft urethroplasty: a detailed analysis of success, morbidity and quality of life in a contemporary patient cohort at a referral center. BMC Urol 2019;19(1):18. DOI:10.1186/s12894-019-0449-5; Urkmez A., Yuksel O.H., Ozsoy E. et al. The effect of urethroplasty surgery on erectile and orgasmic functions: a prospective study. Int Braz J Urol 2019;45(1):118–26. DOI:10.1590/S1677-5538.IBJU.2018.0276; Patel D.P., Elliott S.P., Voelzke B.B. et al. Patient-reported sexual function after staged penile urethroplasty. Urology 2015;86(2):395–400. DOI:10.1016/j.urology.2015.04.055; Beloborodov V., Vorobev V., Kalyagin A. et al. Comparison of efficiency of vascular-preserving urethroplastic methods of the bulbo-membranous part of the urethra. Videosurg Other Miniinvasive Tech 2021;16(1):151–62. DOI:10.5114/wiitm.2020.94281; Vorobev V., Beloborodov V., Seminskiy I. et al. Buccal mucosal graft urethroplasty of the bulbomembranous part of urethra. Cent European J Urol 2020;73(2):199–212. DOI:10.5173/ceju.2020.0021; Kałużny A., Krukowski J., Frankiewicz M., Matuszewski M. The impact of post-urethroplasty erectile dysfunction on the quality of life and treatment satisfaction. Cent European J Urol 2021;74(1):116–20. DOI:10.5173/ceju.2021.0306.R1; Calleja Hermosa P., Campos-Juanatey F., Varea Malo R. et al. Sexual function after anterior urethroplasty: a systematic review. Transl Androl Urol 2021;10(6):2554–73. DOI:10.21037/tau-20-1307; Mundy A.R. Results and complications of urethroplasty and its future. Br J Urol 1993;71(3):322–5. DOI:10.1111/j.1464-410x.1993.tb15951.x; Blaschko S.D., Sanford M.T., Cinman N.M. et al. De novo erectile dysfunction after anterior urethroplasty: a systematic review and meta-analysis. BJU Int 2013;112(5):655–63. DOI:10.1111/j.1464-410X.2012.11741.x; Xie H., Xu Y.M., Fu Q. et al. The relationship between erectile function and complex panurethral stricture: a preliminary investigative and descriptive study. Asian J Androl 2015;17(2):315–8. DOI:10.4103/1008-682X.143312; Dogra P.N., Saini A.K., Seth A. Erectile dysfunction after anterior urethroplasty: A prospective analysis of incidence and probability of recovery – single-center experience. Urology 2011;78(1):78–81. DOI:10.1016/j.urology.2011.01.019; Coursey J.W., Morey A.F., McAninch J.W. et al. Erectile function after anterior urethroplasty. J Urol 2001;166(6):2273–6.; Shakir N.A., Fuchs J.S., Haney N. et al. Excision and primary anastomosis reconstruction for traumatic strictures of the pendulous urethra. Urology 2019;125:234–8. DOI:10.1016/j.urology.2018.05.043; Morey A.F., Kizer W.S. Proximal bulbar urethroplasty via extended anastomotic approach – what are the limits? J Urol 2006;175(6):2145–9; discussion 9. DOI:10.1016/S0022-5347(06)00259-X; Barbagli G., De Angelis M., Romano G., Lazzeri M. Long-term followup of bulbar end-to-end anastomosis: a retrospective analysis of 153 patients in a single center experience. J Urol 2007;178(6):2470–3. DOI:10.1016/j.juro.2007.08.018; Mondal S., Bandyopadhyay A., Mandal M.M., Pal D.K. Erectile dysfunction in anterior urethral strictures after urethroplasty with reference to vascular parameters. Med J Armed Forces India 2016;72(4):344–9. DOI:10.1016/j.mjafi.2016.07.001; Jordan G.H., Eltahawy E.A., Virasoro R. The technique of vessel sparing excision and primary anastomosisfor proximal bulbous urethral reconstruction. J Urol 2007;177(5):1799–802. DOI:10.1016/j.juro.2007.01.036; Andrich D.E., Mundy A.R. Non-transecting anastomotic bulbar urethroplasty: a preliminary report. BJU Int 2012;109(7):1090–4. DOI:10.1111/j.1464-410X.2011.10508.x; Chapman D.W., Cotter K., Johnsen N.V. et al. Nontransecting techniques reduce sexual dysfunction after anastomotic bulbar urethroplasty: results of a multi-institutional comparative analysis. J Urol 2019;201(2):364–70. DOI:10.1016/j.juro.2018.09.051; Haines T., Rourke K.F. The effect of urethral transection on erectile function after anterior urethroplasty. World J Urol 2017;35(5):839–45. DOI:10.1007/s00345-016-1926-z; Palminteri E., Berdondini E., Shokeir A.A. et al. Two-sided bulbar urethroplasty using dorsal plus ventral oral graft: urinary and sexual outcomes of a new technique. J Urol 2011;185(5):1766–71. DOI:10.1016/j.juro.2010.12.103; Spencer J., Blakely S., Daugherty M. et al. Clinical and patientreported outcomes of 1-sided anterior urethroplasty for longsegment or panurethral strictures. Urology 2018;111:208–13. DOI:10.1016/j.urology.2017.08.029; Maciejewski C.C., Haines T., Rourke K.F. Chordee and penile shortening rather than voiding function are associated with patient dissatisfaction after urethroplasty. Urology 2017;103:234–9. DOI:10.1016/j.urology.2016.12.047; Erickson B.A., Granieri M.A., Meeks J.J. et al. Prospective analysis of erectile dysfunction after anterior urethroplasty: incidence and recovery of function. J Urol 2010;183(2):657–61. DOI:10.1016/j.juro.2009.10.017; Kessler T.M., Fisch M., Heitz M. et al. Patient satisfaction with the outcome of surgery for urethral stricture. J Urol 2002;167(6):2507–11.; Carlton J., Patel M., Morey A.F. Erectile function after urethral reconstruction. Asian J Androl 2008;10(1):75–8. DOI:10.1111/j.1745-7262.2008.00349.x; Xie H., Xu Y.-M., Xu X.-L. et al. Evaluation of erectile function after urethral reconstruction: a prospective study. Asian J Androl 2009;11(2):209–14. DOI:10.1038/aja.2008.1; Shabsigh R., Klein L.T., Seidman S. et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998;52(5):848–52. DOI:10.1016/s0090-4295(98)00292-1; Araujo A.B., Durante R., Feldman H.A. et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998;60(4):458–65. DOI:10.1097/00006842-199807000-00011; Anger J.T., Sherman N.D., Webster G.D. The effect of bulbar urethroplasty on erectile function. J Urol 2007;178(3 Pt 1):1009–11. DOI:10.1016/j.juro.2007.05.053; Fu Q., Sun X., Tang C. et al. An assessment of the efficacy and safety of sildenafil administered to patients with erectile dysfunction referred for posterior urethroplasty: a single-center experience. J Sex Med 2012;9(1):282–7. DOI:10.1111/j.1743-6109.2011.02470.x; Zhang D.L., Chen Z., Wang F.X. et al. Adding a vacuum erection device to regular use of Tadalafil improves penile rehabilitation after posterior urethroplasty. Asian J Androl 2019;21(6):582–6. DOI:10.4103/aja.aja_50_19; https://agx.abvpress.ru/jour/article/view/641

الاتاحة: https://agx.abvpress.ru/jour/article/view/641
https://doi.org/10.17650/2070-9781-2023-24-1-100-114

المؤلفون: D. N. Fiev, S. B. Khokhlachev, V. V. Borisov, V. S. Saenko, M. M. Chernenky, A. V. Proskura, Yu. L. Demidko, K. B. Puzakov, D. O. Korolev, N. V. Potoldikova, Zh. Sh. Inoyatov, K. R. Azilgareeva, L. M. Rapoport, Yu. G. Alyaev, P. V. Glybochko, Д. Н. Фиев, С. Б. Хохлачев, В. В. Борисов, В. С. Саенко, М. М. Черненький, А. В. Проскура, Ю. Л. Демидко, К. Б. Пузаков, Д. О. Королев, Н. В. Потолдыкова, Ж. Ш. Иноятов, К. Р. Азильгареева, Л. М. Рапопорт, Ю. Г. Аляев, П. В. Глыбочко

المصدر: Andrology and Genital Surgery; Том 22, № 4 (2021); 36-44 ; Андрология и генитальная хирургия; Том 22, № 4 (2021); 36-44 ; 2412-8902 ; 2070-9781

مصطلحات موضوعية: скорость клубочковой фильтрации, computed tomography, glomerular filtration rate, kidney stone disease, компьютерная томография, мочекаменная болезнь

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/520/439; Carr R.J. A new theory on the formation of renal calculi. Br J Urol 1954;26(2):105—17. DOI:10.1111/j.1464-410x.1954.tb06073.x.; Stoller M.L., Meng M.V, Abrahams H.M., Kane J.P. The primary stone event: a new hypothesis involving a vascular etiology. J Urol 2004;171(5):1920-4. DOI:10.1097/01.ju.0000120291.90839.49.; Kramer G., Klingler H.C., Steiner G.E. Role of bacteria in the development of kidney stones. Curr Opin Urol 2000;10(1):35-8. DOI:10.1097/00042307-200001000-00009.; Martel J., Wu C.-Y., Young J.D. Translocation of mineralo-organic nanoparticles from blood to urine: a new mechanism for the formation of kidney stones? Nanomedicine (Lond). 2016;11(18):2399-404. DOI:10.2217/nnm-2016-0246.; Brown C.M., Ackermann D.K., Purich D.L. EQUIL 93: a tool for experimental and clinical urolithiasis. Urol Res 1994;22(2):119-26. DOI:10.1007/BF00311003.; Bagga H.S., Chi T., Miller J., Stoller M.L. New Insights Into the Pathogenesis of Renal Calculi. Urol Clin North Am 2013;40(1):1-12. DOI:10.1016/j.ucl.2012.09.006.; Robertson W.G. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis 2015;43(Suppl 1):93-107. DOI:10.1007/s00240-014-0737-1.; Asplin J.R., Mandel N.S., Coe F.L. Evidence for calcium phosphate supersaturation in the loop of Henle. Am J Physiol 1996;270(4 Pt 2):F604-13. DOI:10.1152/ajprenal.1996.270.4.F604.; Finlayson B., Reid F. The expectation of free and fixed particles in urinary stone disease. Invest Urol 1978;15(6):442-8.; Helck A., Schonermarck U., Habicht A. et al. Determination of split renal function using dynamic CT-angiography: preliminary results. PLoS One 2014;9(3):e91774. DOI:10.1371/journal.pone.0091774.; Patankar K., Low R.S.-T., Blakeway D., Ferrari P. Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation. Acta radiol 2014;55:753-60.; Barbas A.S., Li Y., Zair M. et al. CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. Clin Transplant 2016;30(9):1028-35. DOI:10.1111/ctr.12784.; Mitsui Y., Sadahira T., Araki M. et al. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol 2018;22(2):453-8. DOI:10.1007/s10157-017-1454-1.; Houbois C., Haneder S., Merkt M. et al. Can computed tomography volumetry of the renal cortex replace MAG3-scintigraphy in all patients for determining split renal function? Eur J Radiol 2018;103:105-11. DOI:10.1016/j.ejrad.2018.04.016.; You S., Ma X., Zhang C. et al. Determination of single-kidney glomerular filtration rate (GFR) with CT urography versus renal dynamic imaging Gates method. Eur Radiol 2018;28(3): 1077-84. DOI:10.1007/s00330-017-5061-z.; Rohrschneider W.K., Hoffend J., Becker K. et al. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction. I. Evaluation of the normal status in an animal model. Pediatr Radiol 2000;30(8):511-22. DOI:10.1007/s002470000270.; Pedersen M., Shi Y., Anderson P. et al. Quantitation of differential renal blood flow and renal function using dynamic contrast-enhanced MRI in rats. Magn Reson Med 2004;51(3):510-7. DOI:10.1002/mrm.10711.; Rohrschneider W.K., Haufe S., Wiesel M. et al. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined staticdynamic MR urography: findings in kidneys with a single collecting system. Radiology 2002;224(3):683-94. DOI:10.1148/radiol.2243011207.; Fiev D., Proskura A., Khokhlachev S. et al. A prospective study of novel mathematical analysis of the contrast-enhanced computed tomography vs renal scintigraphy in renal function evaluation. Eur J Radiol 2020;130:109169. DOI:10.1016/j.ejrad.2020.109169.; Himmelfarb J., Ikizler T.A. Chronic kidney disease, dialysis, and transplantation: companion to Brenner and Rector's the kidney. Elsevier, 2018.; Moeller T.B., Reif E. Normal Findings in CT and MRI. Shtuttgart, New York: Thieme, 2000.; Mudraia I.S., Kirpatovskii V.I. [The functional assessment of the upper urinary tract by the methods of 2-frequency impedance measurement and multichannel impedance ureterography (In Russ.)]. Urol Nefrol (Mosk) 1993;5:4-9.; Wen J.G., Frokiffir J., J0rgensen T.M., Djurhuus J.C. Obstructive nephropathy: An update of the experimental research. Urol Res 1999;27(1):29-39. DOI:10.1007/s002400050086.; Docherty N.G., O'Sullivan O.E., Healy D.A. et al. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 2006;290(1):F4-13.; https://agx.abvpress.ru/jour/article/view/520

الاتاحة: https://agx.abvpress.ru/jour/article/view/520
https://doi.org/10.17650/1726-9784-2021-22-4-36-44

المؤلفون: E. N. Gasanov, E. V. Shpot, A. A. Magomedov, D. V. Chinenov, A. V. Proskura, P. I. Golovnya, E. S. Kapralova, V. S. Tikhonova, L. M. Rapoport, Э. Н. Гасанов, Е. В. Шпоть, А. А. Магомедов, Д. В. Чиненов, А. В. Проскура, П. И. Головня, Е. С. Капралова, В. С. Тихонова, Л. М. Рапопорт

المصدر: Andrology and Genital Surgery; Том 22, № 4 (2021); 60-67 ; Андрология и генитальная хирургия; Том 22, № 4 (2021); 60-67 ; 2412-8902 ; 2070-9781

مصطلحات موضوعية: простатэктомия, quality of life, prostate cancer, low oncological risk, prostatectomy, качество жизни, рак предстательной железы, низкий онкологический риск

وصف الملف: application/pdf

Relation: https://agx.abvpress.ru/jour/article/view/523/442; D'Amico A.V., Whittington R., Malkowicz S.B. et al. Biochemical outcome after radicalprostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Jama 1998;280(11):969-74. DOI:10.1001/jama.280.11.969.; Hamdy F.C., Donovan J.L., Lane J.A. et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med 2016;375(15):1415-24. DOI:10.1056/NEJMoa1606220.; Preston M.A., Feldman A.S., Coen J.J. et al. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol 2015;33(9):383.e9-16. DOI:10.1016/j.urolonc.2015.04.015.; Loeb S. Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer. Eur Urol 2018;73(6):868-9. DOI:10.1016/j.eururo.2017.10.037.; EAU Guidelines: prostate cancer, 2019. Available at: https://uroweb.org/guideline/prostate-cancer/.; Bill-Axelson A., Holmberg L., Garmo H. et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370(10):932-42. DOI:10.1056/NEJMoa1311593.; Tosoian J.J., Mamawala M., Epstein J.I. et al. Intermediate and Longer-Term Outcomes From a Prospective ActiveSurveillance Program for FavorableRisk Prostate Cancer. J Clin Oncol 2015;33(30):3379-85. DOI:10.1200/JCO.2015.62.5764.; Choo R., Klotz L., Danjoux C. et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167(4):1664-9.; Klotz L., Vesprini D., Sethukavalan P. et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015;33(3):272-7. DOI:10.1200/JCO.2014.55.1192.; Steineck G., Helgesen F., Adolfsson J. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347(11):790-6. DOI:10.1056/NEJMoa021483.; Matthew A.G., Raz O., Currie K.L. et al. Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomy. J Psychosoc Oncol 2018;36(2):159-74. DOI:10.1080/07347332.2017.1342733.; Liatsikos E.N., Assimakopoulos K., Stolzenburg J.U. Quality of life after radical prostatectomy. Urologia Internationalis 2008;80(3):226—30. DOI:10.1159/000127331.; Han M., Partin A.W., Zahurak M. et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169(2):517-23. DOI:10.1016/S0022-5347(05)63946-8.; Гасанов Э.Н., Чиненов Д.В., Акопян Г.Н. и др. Первые результаты активного наблюдения за больными раком предстательной железы низкого онкологического риска. Андрология и генитальная хирургия 2021;22(2):78-83. DOI:10.17650/1726-9784-2021-22-278-83.; Bruinsma S.M., Roobol M.J., Carroll P.R. et al. Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure. Nat Rev Urol 2017;14(5):312-22. DOI:10.1038/nrurol.2017.26.; https://agx.abvpress.ru/jour/article/view/523

الاتاحة: https://agx.abvpress.ru/jour/article/view/523
https://doi.org/10.17650/1726-9784-2021-22-4-60-67

المؤلفون: K. I. Davletova, E. S. Mikhaylova, N. A. Varaksin, L. P. Zhurakovsky, A. V. Proskura, S. V. Sidorov, A. I. Autenshlyus, К. И. Давлетова, Е. С. Михайлова, Н. А. Вараксин, И. П. Жураковский, А. В. Проскура, С. В. Сидоров, А. И. Аутеншлюс

المصدر: Medical Immunology (Russia); Том 21, № 6 (2019); 1115-1126 ; Медицинская иммунология; Том 21, № 6 (2019); 1115-1126 ; 2313-741X ; 1563-0625 ; 10.15789/1563-0625-2019-6

مصطلحات موضوعية: лимфогенное метастазирование, blood immune cells, polyclonal activators, breast cancer, invasive ductal carcinoma of no special type, lymph nodes metastasis, иммунокомпетентные клетки крови, поликлональные активаторы, рак молочной железы, инвазивная карцинома молочной железы неспецифического типа

وصف الملف: application/pdf

Relation: https://www.mimmun.ru/mimmun/article/view/1764/1208; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4965; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4966; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4967; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4968; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4969; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4970; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4971; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4972; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4973; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4974; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4975; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4976; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4977; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4978; https://www.mimmun.ru/mimmun/article/downloadSuppFile/1764/4979; Соснина А.В., Великая Н.В., Вараксин Н.А., Гришаев М.П., Аутеншлюс А.И. Роль цитокинов в патогенезе злокачественных новообразований. Новосибирск: Офсет, 2014. 128 с.; Cetean S., Cainap C., Constantin A., Cainap S., Gherman A., Oprean L., Hangan A., Oprean R. The importance of the granulocyte-colony stimulating factor in oncology. Clujul Med., 2015, Vol. 88, no. 4, pp. 468-472.; Coppe J., Desprez P., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol., 2010, Vol. 5, pp. 99-118.; Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, Vol. 365, no. 1687, p. 717.; Gameiro C.M., Romao F., Castelo-Branco C. Menopause and aging: changes in the immune system - a review. Maturitas, 2010, Vol. 67, no. 4, p. 316.; Garcla-Tunon I., Ricote M., Ruiz A.A., Fraile B., Paniagua R., Royuela M. Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer, 2007, Vol. 7, p. 158.; Giordano S.B., Gradishar W. Breast cancer: updates and advances in 2016. Curr. Opin. Obstet. Gynecol., 2017, Vol. 29, no. 1, pp. 12-17.; Gonzalez H., Hagerling C., Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes and Dev., 2018, Vol. 32, no. 19-20, pp. 1267-1284.; Herrera A.C., Panis C., Victorino V.J., Campos F.C., Colado-Simao A.N., Cecchini A.L., Cecchini R. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol. Immunother., 2012, Vol. 61, no. 11, pp. 2193-201.; Keunhee O., Ok-Young L., Yeonju P., Myung W.S., Dong-Sup L. IL-1 p induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells. BMC Cancer, 2016, Vol. 16, no. 1, p. 724.; Li Z., Jiang J., Wang Z., Zhang J., Xiao M., Wang C., Lu Y., Qin Z. Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. Cancer Res., 2008, Vol. 68, no. 21, p. 94.; Mauer J., Denson J.L., Bruning J.C. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol., 2015, Vol. 36, no. 2, pp. 92-101.; Nagini S. Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med. Chem., 2017, Vol. 17, no. 2, pp. 152-163.; Pfeilschifter J., Kbditz R., Pfoh M., Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev., 2002, Vol. 23, no. 1, pp. 90-119.; Szomolay B., Eubank T.D., Roberts R.D., Marsh C.B., Friedman A. Modeling the inhibition of breast cancer growth by GM-CSF. J. Theor. Biol., 2012, Vol. 303, no. 141 p. 51.; Todaro M., Lombardo Y., Francipane M.G., Alea M.P., Cammareri P., Iovino F., Di Stefano A.B., di Bernardo C., Agrusa A., Condorelli G., Walczak H., Stassi G. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ., 2008, Vol. 4, no. 762, p. 72.; Tortorella C., Simone O., Piazzolla G., Stella I., Antonaci S. Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res. Rev., 2007, Vol. 6, no. 2, pp. 81-93.; Yazdkhasti M., Tourzani Z.M., Roozbeh N., Hasanpour V. Saeieh S.E., Abdi F. The association between diabetes and age at the onset of menopause: a systematic review protocol. Syst. Rev., 2019, Vol. 8, no. 1, p. 80.; https://www.mimmun.ru/mimmun/article/view/1764

الاتاحة: https://www.mimmun.ru/mimmun/article/view/1764
https://doi.org/10.15789/1563-0625-2019-6-1115-1126